The virus poses a more serious risk to high-risk groups such as the elderly, young children, and individuals with chronic ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

ACIP votes to expand recommendation for Pfizer’s RSV vaccine Abrysvo to include adults aged 50 to 59 at increased risk of disease: New York Saturday, April 19, 2025, 10:00 Hrs [ ...

More information: Rina Hashimoto et al, Human iPS cell–derived respiratory organoids as a model for respiratory syncytial virus infection, Life Science Alliance (2025). DOI: 10.26508/lsa.

TUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against respiratory syncytial virus (RSV) ...

The US Department of Health and Human Services (HHS) has launched a $500m initiative to accelerate the development of universal vaccines targeting viruses with pandemic potential, including influenza, ...

The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called ...

In a recent study of a population of infants, 72% of infants were found to be immunized against respiratory syncytial virus.